Maureen Sartor, PhD
Manage Your Profile
Center Memberships
-
Center MemberRogel Cancer Center
-
Center MemberAI and Digital Health Innovation
Research Overview
The Sartor laboratory has both methodological and biomedical areas of focus. Their methodological focus is bioinformatics methods and tools for the analysis of genome-wide regulatory and epigenomics data, and for assessing the biological/clinical significance of results. For instance, Dr. Sartor is a member of the Impact of Genomic Variants on Function (IGVF) NIH Consortium, for which she is developing a coupled tensor-matrix completion method to prioritize disease-specific variant-gene target pairs. The Sartor Lab also focuses on multi-omics approaches for biomarker and treatment-target discovery in disease, focusing specifically on Amyotrophic Lateral Sclerosis (ALS) and head and neck squamous cell carcinomas (HNSCC). Dr. Sartor is PI of an R01 studying downstream consequences of HPV integration in HPV-associated HNSCC, and Co-PI of a Transformative R01 linking environmental exposures with multi-omics in ALS. Being formally trained in biostatistics, Dr. Sartor uses machine learning and statistical approaches to make advances in the above areas.
Links
Sartor Lab
Recent Publications
-
Núñez FJ, Banerjee K, Mujeeb AA, Mauser A, Tronrud CE, Zhu Z, Raghuram S, Sheth MR, Pena Agudelo JA, Zelaya J, Taher A, Kadiyala P, Carney SV, Garcia-Fabiani MB, Comba A, Alghamri MS, McClellan BL, Klaiss A, Nwosu ZC, Hong HS, Sajjakulnukit P, Qin T, Sartor MA, Ljungman M, Welch JD, Cheng SY, Lowenstein PR, Lahann J, Lyssiotis CA, Castro MG. Nature Communications, 2026 Dec 1; 17 (1):Journal ArticleAutophagy inhibition sensitizes radiotherapy responses in high-grade mutant IDH1 glioma
DOI:10.1038/s41467-026-77320-7 PMID: 42760279 -
Zhang Y, Ntsiful DA, Israel R, Vandenburg B, Barnett S, Riethoven J-J, Clarke J, Lagisetty K, Lin J, Reddy RM, Chang A, Odell D, DiFeo A, Sartor MA, Kresty LA. Cell Death and Disease, 2025 May 29;Journal ArticleIdentification of isoform switching events linked with esophageal adenocarcinoma patient survival informs novel prognostic and therapeutic targets, In Revision
-
Lima SM, Ahn J, Dash C, Hseih M-C, Jones RR, Mabvakure B, Muhsen R, Patil S, Peluso A, Promprasert C, Qin T, Ruterbusch JJ, Sartor MA, Schwartz AG, Wenzlaff AS, Zhang R, Stoffel EM, Purrington KS, Rozek LS. 2026 Sep 29;PreprintEpigenetic Exposure Signatures Distinguish Early-Onset from Later-Onset Colorectal Cancer in a Racially Diverse US Cohort: Findings from the Disparities and Cancer Epidemiology (DANCE) Study.
DOI:10.64898/2026.09.28.26363311 PMID: 42856386 -
Lawas MM, Hsieh M, Patil S, Mohebbi E, Zhang R, Ahn J, Benjamin W, Chinn SB, Witek M, Mabvakure B, Duttargi A, Cruz LM, Garb B, Li S, D'Silva NJ, Sartor MA, Rozek LS. Neoplasia United States, 2026 Sep 1; 79:Journal ArticleThe importance of HPV testing in oropharyngeal cancer in two US populations
DOI:10.1016/j.neo.2026.101323 PMID: 42391786 -
Fu S, Miao B, Shao W, Coarfa C, Kumar R, Kuntala PK, Park B, Grimm SL, Jangid R, Colacino JA, Xing X, Li D, Liu S, Hamanaka RB, Lalancette C, Sartor MA, Krapp C, Crawford GE, Patisaul HB, Wiltshire T, Consortium TI, Aylor D, Biswal S, Mutlu GM, Rajagopalan S, Tang W-Y, Dolinoy DC, Wang T, Bartolomei MS, Walker CL, Svoboda LK, Zhang BA. 2026 Aug 27; bioRxiv,PreprintLifecourse sex-specific molecular response to early-life exposures of toxic substances
DOI:10.64898/2026.08.20.746014 -
Purrington K, Hsieh M-C, Patil S, Mabvakure B, Ahn J, Zhang R, Ruterbusch JJ, Samdani R, Lee G, Wenzlaff A, Latif S, Dash C, Sartor M, Schwartz AG, Stoffel EM, Rozek LS. 2026 Jun 29;PreprintRace and Socioeconomic Status Impact Survival from Early and Late-Onset Colorectal Cancer.
DOI:10.64898/2026.06.24.26356439 PMID: 42428080 -
Mabvakure BM, Promprasert P, Martinez Cruz L, Patil S, Barros J, Hayhurst M, Mohebbi E, de la Caridad Delgado Herrera D, Lee G, Latif S, Williams F, Samdani R, Duttargi A, Berhane B, Besufikad E, Tadesse S, Jibril Suleiman A, Lefante C, Hsieh M-C, Purrington K, Adjei E, Qin T, Sartor M, Stoffel EM, Rozek LS. 2026 Jun 29;PreprintSOMATIC MUTATION PROFILES IN COLORECTAL CANCERS DIFFER BY POPULATION.
DOI:10.64898/2026.06.24.26356431 PMID: 42428056 -
Chen X-W, Wang H, Bajaj K, Zhang P, Ma D, Bai Y, Liu H-H, Adams E, Baines A, Yu G, Sartor MA, Zhang B, Yi Z, Lin J, Young SG, Schekman R, Ginsburg D. Elife, 2026 Jun 24; 15:Journal ArticleCorrection: SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion.
DOI:10.7554/eLife.112375 PMID: PMC13293604
Featured News & Stories
Elysia Chou receives Rackham Predoctoral Fellowship
Researchers develop models to help diagnose ALS earlier through blood biomarkers